Irinotecan trials for Colorectal Cancer Metastatic

All Irinotecan trials · All Colorectal Cancer Metastatic trials

Phase breakdown

Recruiting trials studying Irinotecan for Colorectal Cancer Metastatic

• Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
  NCT06547203 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
  NCT05727163 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
  NCT06714357 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations

Common questions

How many trials study Irinotecan for Colorectal Cancer Metastatic?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.